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Abstract In plants, spirostanol glycosides (steroid saponins) are 
known to be formed from furostanol glycosides during posthar- 
vest treatment and storage. Furostanol glycoside 26-O-fl-glucosi- 
dase (F26G) involved in this conversion was purified to apparent 
homogeneity for the first time from Costus speciosus rhizomes 
which accumulate these glycosides. The enzyme was highly spe- 
cific for cleavage of the C-26-bound glucose moiety of furostanol 
glycosides howing Km for protogracillin of 50 pM. Glucono-l,5- 
lactone, a typical fl-glucosidase inhibitor, and diosgenin, an agly- 
cone of spirostanol glycosides, strongly inhibited the enzyme ac- 
tivity. The purified F26G is dimeric with a native apparent molec- 
ular weight of 110,000 consisting of subunits of 54,000 and 
58,000. The N-terminal sequence of the 54,000 protein has a high 
similarity to the sequences found in N-terminal regions of known 
plant fl-glucosidases. 
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1. Introduction 
Spirostanol glycosides howing typical saponin characteris- 
tics such as antifungal and haemolytic activities are formed 
from furostanol glycosides which do not show any of these 
activities (Scheme 1) [1 3]. This conversion proceeds during 
postharvest treatment and storage of the plant material [2]. 
Many plant fl-glucosidases have been found to be specific for 
their native substrates [4,5]. Thus, we use the term 'furostanol 
glycoside 26-O-fl-glucosidase (F26G)' for the enzyme involved 
in the above conversion since it is also expected to be specific 
for removal of the C-26-bound glucose of furostanol glycosides. 
There have been only a few reports on the F26G. In 1969, 
Joly et al. demonstrated conversion of [4-~4C]protodioscin to 
dioscin by a Dioscoreafloribunda homogenate [6]. Several Rus- 
sian groups have detected the oligofurostanoside-specific fl- 
glucosidase activity in three plants which contain furostanol 
and spirostanol glycosides [7 9]. They estimated the enzyme 
activity by determining decrease of oligofurostanosides moni- 
tored by their specific color reaction with p-dimethylaminoben- 
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zaldehyde. In leaves of D. deltoidea, more than half of the 
activity was found in the chloroplast fraction [7]. In leaves of 
Yucca gloriosa, the activity was manifested to be in mesophyll 
tissue [8]. The enzyme in inflorescences of Allium erubescens 
showed K m for deltoside, a furostanol glycoside of this plant, 
of 23 mM [9]. However, the enzyme responsible for the forma- 
tion of spirostanol glycosides has not been purified nor charac- 
terized from any sources yet. 
Although the biological activities of spirostanol and fu- 
rostanol glycosides have been well-described [1,10], little is 
known about their functions in intact plants. In order to eluci- 
date their physiological roles, we have been studying the F26G 
in Costus speciosus, a Gingiberaceous tropical plant, known to 
contain furostanol and spirostanol glycosides [11-15]. We have 
established a highly sensitive F26G assay method using HPLC 
and successfully detected the activity in the rhizomes which 
accumulate furostanol glycosides [16]. In this publication, we 
report the first purification and characterization f F26G from 
C. speciosus rhizomes. 
2. Materials and methods 
2.1. Materials 
(2 speciosus used for experiments was cultivated in a greenhouse of
the Experiment Station for Medicinal Plant Studies of University of 
Tokyo in Chiba prefecture, Japan. Furostanol and spirostanol glyco- 
sides were isolated and identified from rhizomes of (2 speciosus [15]. 
fl-Sitosterol was isolated from soybean. All other reagents were of 
analytical grade. Protein was quantified by Bradford's method and a 
calibration curve obtained with bovine-serum albumin [17]. 
2.2. Purification of furostanol glycoside 26-O-~-glucosidase ( F26G) 
Rhizomes of (2 speciosus free from other organs were sliced into 
small pieces and shock-frozen i dry ice/acetone. The frozen materials 
(36 g) were homogenized with a Waring blender in 110 ml of 0.1 M 
potassium phosphate buffer, pH 7.0, containing Polyclar AT (3%, w/v) 
and sodium isoascorbate (0.3%, w/v). Unless otherwise stated, purifica- 
tion of F26G was performed at 4°C. After centrifugation at12,000 × g 
for 30 min, the supernatant (crude extract) was subjected to ammonium 
sulfate fractionation. The precipitates formed between 30 to 60% satu- 
ration of ammonium sulfate were dissolved in 5 ml of buffer A (20 mM 
potassium phosphate buffer, pH 7.0) and then passed through PD-10 
columns (Pharmacia) equilibrated with buffer A to remove ammonium 
sulfate and other low molecular weight compounds. Protein containing 
fractions were pooled and loaded onto a DEAE-cellulose column 
(Whatmann DE52, 16 × 40 mm) equilibrated with buffer A. After wash- 
ing the column with 80 ml of buffer A, the protein with F26G activity 
was eluted with 40 ml of buffer A containing 0.5 M KCI. The pooled 
active fraction was precipitated with ammonium sulfate (60% satura- 
tion), dissolved in 2.5 ml of buffer A and applied to a PD-10 column 
equilibrated with buffer A. Solid ammonium sulfate was added up to 
a final concentration of 1 M and insoluble materials were removed by 
Micropure-0.22 (Amicon). Then the clear protein solution was sub- 
jected to HPLC using a TSKgel Ether-5PW column (Tosoh; 7.5 × 75 
mm) equilibrated with buffer A containing 1M ammonium sulfate at 
room temperature. Bound protein was eluted by linearly decreasing the 
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ammonium sulfate concentration to 0 M. Buffer of the pooled active 
fractions was exchanged to buffer A by ultrafiltration using Centricon 
30 (Amicon) and the resultant concentrated protein solution was subse- 
quently subjected to HPLC using a TSKgel DEAE-5PW column 
(Tosoh; 7.5 × 75 mm). F26G was eluted at room temperature with a 
linear gradient of 0.1~).5 mM KC1 in buffer A and either used directly 
for further studies or stored at 4°C. No significant loss of activity was 
observed at least for 3 weeks under this condition. 
2.3. Enzyme assays 
The F26G assay mixture contained 0.4 mM protogracillin, l0 ktl of 
EGME, 15 ,ul of appropriately diluted enzyme solution and 50 mM 
sodium acetate buffer, pH 5.0, in a total volume of 150 pl. Reaction was 
initiated by adding the enzyme solution. After being incubated for 10 
min at 40°C, produced gracillin was extracted with 150/4 n-BuOH 
saturated with H20 and determined by HPLC [16]. For the substrate 
specificity study, the concentration f glycosidic substrate was adjusted 
to 1 mM. Reaction was terminated by boiling for 3 min and glucose 
production was measured by glucose oxidase procedure [18]. When 
pNPG was used as a substrate, the reaction was stopped by adding 0.3 
M Na2CO 3 and liberated pNP was determined by absorbance at 400 
nm. The amount of protein in the reaction mixture was adjusted to keep 
the reaction velocity linear with time up to 30 min. When furostanol 
glycoside, protogracillin or protodioscin, was used as a substrate, the 
amount of released D-glucose was in good accordance with that of 
produced spirostanol glycoside, gracillin or dioscin, respectively. All 
assays were performed in duplicate and values shown represent the 
mean of both trials. 
2.4. Analytical gel filtration 
Gel filtration HPLC was performed using columns of G4000SWx[ 
(Tosoh, 7.8 × 300 mm) and G3000SWxL (Tosoh, 7.8 x 300 ram) con- 
nected in series (eluent, 0.1 M potassium phosphate buffer, pH 7.0. 
containing 0.2 M KCI; flow rate, 0.4 ml/min; detection, UV280 nm) at 
room temperature. The column was calibrated with proteins of known 
M r. Cytochrome c (12,400); Adenylate kinase (32,0003; Enolase 
(67,000); Lactate dehydrogenase (142,000); Glutamate dehydrogenase 
(290,000); and gave a linear relationship between the logarithm of Mr 
and retention time. 
2.5. Protein sequencing 
GIc-O 
~~v. (5  \ ~Glucosidase 
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Scheme 1 
The purified enzyme was subjected to 7.5% SDS-PAGE followed by 
electroblotting onto polyvinylidenedifluoride membrane (ProBlott, Ap- 
plied Biosystems). The 54,000 and 58,000 protein bands were excised 
separately and subjected to N-terminal sequence analysis by using an 
automated protein sequencer (Applied Biosystems 473A). 
2.6. Preparation of antibodies against the synthetic peptide 
The sequence of amino acid residues 3to 13 of the 54,000 protein was 
used to direct synthesis of a 12-amino acid-long peptide [3pro-Ala-Glu- 
Val-Val-Leu-Gly-Arg-Ser-Ser-13phe-(Lys)] using a MilliGen 9020 Pep- 
Synthesizer. The synthetic peptide was coupled to keyhole-limpet he- 
mocyanin using glutaraldehyde [19]. Polyclonal antibodies to this con- 
jugate were raised in rabbits by injecting 3x with 1 mg of the conjugate 
every 2 weeks. Blood samples were obtained 1 week after the last 
injection. 
3. Results 
When the rhizomes were extracted with 0.1 M potassium 
soluble and insoluble fractions in a ratio of 2 : 3 by centrifuga- 
tion at 107,000 x g for 60 min [16]. Several attempts to solubilize 
the insoluble fraction by KCI or detergents, such as Triton 
X-100, were unsuccessful. However, almost all the F26G activ- 
ity was found in the 107,000xg soluble fraction when the 
rhizomes were homogenized with Polyclar AT and sodium 
isoascorbate. Therefore, this extraction method was used in the 
following experiments. 
A four-step purification procedure afforded a 25-fold purifi- 
cation of F26G with 15% recovery of activity (Table 1). The 
resultant DEAE-5PW fraction gave only two bands with Mr of 
54,000 and 58,000 on SDS-PAGE (Fig. 13 and eluted as a single 
symmetrical peak associated with all the F26G activity from an 
HPLC gel fi ltration column (Fig. 2). The apparent native Mr 
of F26G was determined to be 110,000 after calibration with 
marker proteins. Since this peak fraction also gave only two 
phosphate buffer, pH 7.0, the F26G activity was separated into 
Table 1 
Purification of F26G from C. speciosus rhizomes 
bands on SDS-PAGE which were stained equally with 
Purification step Total protein Total activity Specific activity Yield Purification 
(mg) ~kat) (nkat/mg) (%) (x-fold) 
Crude extract 59.3 13.1 221 100 1.0 
30 60% (NH4)2SO 4 35.3 7.8 221 60 1.0 
DE 52 24.6 6.5 264 50 1.2 
Ether-5PW 0.43 1.8 4190 14 19.0 
DEAE-5PW 0.37 2.0 5420 15 24.5 
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Fig. 1. Purification of F26G monitored by electrophoretic analysis. 
SDS-PAGE (9.6%) was performed as described by Laemmli [26] and 
the gel was silver stained. Lane 1, fraction eluted from HPLC on 
DEAE-5PW (0.8/lg). Lane 2, protein markers: bovine serum albumin 
(66,000); ovalbumin (45,000); carbonic anhydrase (29,000); trypsinogen 
(24,000). 
Coomassie brilliant blue (data not shown), the native F26G 
appears to be a heterodimeric protein. 
The optimum pH of the purified enzyme was determined 
between 5.0 and 5.5 when protogracillin was used as a sub- 
strate. The purified F26G showed saturation kinetics and the 
Km for protogracillin was calculated to be 50 /IM by Lin- 
eweaver-Burk plots. This value was 4 x 102 x smaller than that 
of oligofurostanoside-specific fl-glucosidase in A. erubescens 
for deltoside [9]. 
The fl-glucosidase activity of the purified F26G on several 
fl-glucosides is summarized in Table 2. Potential substrates 
tested included two major furostanol glycosides of C. speciosus 
rhizomes (protogracillin and protodioscin) [15] and three com- 
mercially available fl-glucosides (amygdalin, gentiobiose and 
octyl fl-glucoside), all of which produce primary alcohols on 
hydrolysis. Protodioscin was as good a substrate as protogra- 
cillin, but other fl-glucosides examined were not. On the other 
hand, the furostanol glycosides were found to be quite poor 
substrates for three commercially available nzymes (fl-glucosi- 
dase from almond, cellulases from Tricoderma viride and Asper- 
gillus niger, data not shown). These results suggest hat the 
F26G is highly specific for the cleavage of C-26-bound glucose 
moiety of furostanol glycosides. 
Two typical fl-glucosidase inhibitors were tested for their 
effects on the purified F26G (0.3 to 10 raM). Glucono-l,5- 
Table 2 
Substrate specificity of purified F26G 
Substrate nmol b-glucose or pNP released 
Protogracillin 53 
Protodioscin 47 
Amygdalin < 0.1 * 
Cellobiose < 0.1 * 
Gentiobiose < 0.1 * 
Octyl fl-b-glucoside < 0.1 * 
Prunasin < 0.1" 
pNPG 0.93 
*Amount of produced b-glucose was under detection limit. 
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lactone [20] was effective in inhibiting F26G, showing 50% 
inhibition at 250 pM, while conduritol f -epoxide [21], was less 
effective (IC5o was 2.4 mM). Three typical sterols were also 
investigated for their effects (0.01 to 5 mM) on the purified 
F26G. Diosgenin, an aglycone of spirostanol glycosides, inhib- 
ited 50% of the F26G activity at 79/~M, near the K m of the 
F26G for protogracillin. By contrast, fl-sitosterol and cholest- 
erol showed little influence on the activity (IC5o were 1.4 mM 
and 2.8 mM, respectively). 
The purified F26G gave two bands which M r of 54,000 and 
58,000 on SDS-PAGE (Fig. 1), The 58,000 protein appeared to 
be N-terminal blocked since it did not give a signal during 
automated sequencing. On the other hand, the 54,000 protein 
yielded a 20-amino acid sequence quantitatively. It contained 
a well-conserved plant fl-glucosidase N-terminal region motif 
Arg-X-X-Phe-Pro-X-X-Phe-X-Phe-Gly (Fig. 3). Arg- 10 to Gly- 
20 of the F26G 54,000 protein is identical to Arg-37 to Gly-47 
of a fl-glucosidase from Trifolium repens except for one amino 
acid residue (Fig. 3). 
A polyclonal antibody directed against he synthetic N-ter- 
minal peptide of the 54,000 protein has been prepared. On the 
western blot of SDS-PAGE gels, this antiserum reacted not 
only with the 54,000 protein but also with the 58,000 one (data 
not shown). This result suggests that these two proteins are very 
similar, at least in their N-terminal sequences. A similar situa- 
tion was reported for a fl-glucosidase from lodgepole pine 
xylem, which showed two immunologically similar proteins dif- 
fering in Mr (24,000 and 28,000) on SDS-PAGE and the smaller 
one is presumed to be a processing or degradation product of 
the larger one [22]. The 54,000 protein of F26G might be also 
derived from the 58,000 protein. 
4. Discussion 
We have been studying furostanol 26-O-fl-glucosidase 
(F26G) involved in the postharvest conversion of furostanol 
glycosides to spirostanol glycosides in C. speciosus. The F26G 
in rhizomes may easily aggregate to become an insoluble form 
Mr 290 142 67 32 12.4 
j \ 
I ' I ' ' I 
40 50 60 
Retention time (min) 
Fig. 2. Gel filtration HPLC of the purified F26G. The DEAE-5PW 
fraction was applied to the gel filtration HPLC as described inmaterials 
and methods. M, values are given on upper ordinate from calibration 
with marker proteins. 
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GL JY31  28  
GL JY I4  20  
S40483 08  
A48860 66  
$23940 22  
CBG24 02  
Bg lp  62  
RxxFPxGFxFG 
Fig. 3. Optimal N-terminal mino acid sequence alignment ofthe F26G 
(54,000 subunit) and other plant fl-glucosidases. Amino acid sequence 
comparisons were carried out with BLASTP v. 1.3.11 on Protein Iden- 
tification Resource release 44.0 and reference [22]. Sequences are 
aligned to maximize similarity. The 'plant ]~-glucosidase N-terminal 
motif is shown in the top line. Identical residues are shown as white 
character on a black background. The number to the left of the se- 
quence represents he first residues in each line. GLJY31 and GLJYI4. 
Trifolium repens fl-glucosidases; $40483, Hordeum vulgare fl-glucosi- 
dase; A48860, Zea mays fl-glucosidase; $23940, Manihot esculenta fl- 
glucosidase; CBG24, Pinus contorta fl-glucosidase; Bglp, Arena sativa 
fl-glucosidase. 
in the presence of phenolic ompounds without the addition of 
Polyclar AT and sodium isoascorbate to the extraction buffer. 
We have obtained highly purified F26G protein as judged by 
SDS-PAGE followed by silver staining (Fig. 1) and gel filtration 
HPLC (Fig. 2) although only about 25-fold purification could 
be achieved (Table 1). Since the yield is 15%, it suggests that 
the F26G may be a predominant protein constituting almost 
4% of the total protein in the rhizomes of C. speciosus, where 
furostanol glycosides, the native substrates of F26G, are accu- 
mulated [14]. Enzymatic reaction proceeds only after plants are 
harvested. Under normal physiological conditions, the enzyme 
and its substrate might be compartmented spatially and/or 
chemically. The co-oceurrence of glucosides and enzymes in- 
volved in their degradation has been reported in several cyano- 
genic plants [23,24] and chamomile plant which contains fla- 
vone glucoside [25]. Study on the subcellular localization of 
F26G and its substrate would clarify the reason why spiro- 
stanol glycosides are not formed under normal physiological 
conditions. 
The purified F26G showed high specificity for the removal 
of C-26-bound glucose moiety of furostanol glycosides and was 
strongly inhibited by diosgenin. These results suggest hat the 
enzyme recognizes pirostanol and furostanol skeletons. We 
have already obtained several internal peptide fragments of the 
purified F26G. Based on the amino acid sequences of these 
peptides, oligonucleotide primers have been designed to be used 
for isolation of its cDNA clone by polymerase chain reactions. 
Molecular characterization f the F26G is now in progress and 
the results would give some clues to elucidate mechanism of its 
specific hydrolytic action and reveal whether the 54,000 protein 
is a degradation product of the 58,000 protein or not. 
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